Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q3 2021 call → NOWe need to determine if the company is currently living through a defined waiting period it is paying for out of its own pocket, with a specific near-dated event that ends the wait, and that this is the main current work. Let's analyze the transcript. The company is Alignment Healthcare, a Medicare Advantage plan. They discuss their performance, growth, and investments. Key points: - They mention "redeploy some of our outperformance towards driving 2022 and 2023 growth" - that's investing for future growth. - They talk about "making the right foundational investments to date to ensure sustainable growth over the long term." - They mention "we are continuing to focus our efforts on accretive ways to deploy capital, including M&A in both existing markets as well as new markets." - They discuss "new market launches" and "AEP" (Annual Election Period) which is the enrollment period for Medicare Advantage plans. They are in the middle of AEP (they say "we're just a couple of weeks in the AEP"). - They talk about "our emphasis on tailoring products" and "recently announced several leading health system partnerships to support the launch of our PPO products" - these are new products. - They mention "we are doubling down on our efforts with our provider partners to continue to strive for even greater outcomes" - that's ongoing. Now, is there a specific waiting period where they are paying costs now for something not yet earning? They mention "we anticipate that those expenses will still be incurred in the fourth quarter" regarding SG&A timing. They also mention "we look for accretive ways to invest our year-to-date gross profit outperformance toward our 2022 and 2023 growth efforts." That's investment, but not necessarily a defined waiting period with a specific near-dated event. They talk about "new market launches" - they are launching new markets. They have "beachheads" they are setting up. They mention "we are launching our new markets right now, and we are bringing onboard some of our new hires to support that new growth" - that's paying for people before they generate revenue. But is that a defined waiting period? They are in the middle of AEP, which is the enrollment period. The benefit of AEP will be seen in January 2022 when new members start. So they are incurring costs now (marketing, sales, etc.) for members who will start in January.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.